BACKGROUND: Secondary central nervous system lymphoma (SCNSL) is a rare and aggressive disease, which is defined as secondary central nervous system (CNS) involvement in patients with systemic lymphoma. According to previous reports, SCNSL presents mostly with leptomeningeal spread; however, our experience differs. In the present study, we demonstrate the diversity of magnetic resonance imaging (MRI) patterns in SCNSL. PATIENTS AND METHODS: Initial morphological MRI findings in 21 patients (10 women and 11 men with mean age 62.3±16.2 years) with SCNSL were retrospectively evaluated. All patients suffered from neurological symptoms and underwent MRI, and all cases were histologically verified. Twelve patients were treated by corticosteroids at the time of the initial MRI. RESULTS: Parenchymal lesions were present in 18 of 21 cases (85.7%), solitary meningeal infiltration was present in 1 patient (4.8%), leptomeningeal infiltration in combination with hypophyseal involvement in 1 patient (4.8%), and solitary involvement of the sixth cranial nerve (CN) was found in 1 patient (4.8%). Multiple lesions were present in 11 of 21 cases (52.4%). Diffusion restriction in all or part of the lesion was detected in 14 of 18 cases (77.8%). All parenchymal lesions had an infiltrative appearance and most enhanced homogenously (11 of 17 cases; 64.7%). A combination of parenchymal and meningeal involvement was found in 10 of 21 cases (47.6%). Infiltration of the CNs, basal ganglia, corpus callosum, and ependyma was present in 8 of 21 cases (38.1%) for each of the abovementioned structures; hypothalamic-hypophyseal axis was affected in 7 of 21 cases (33.3%). CONCLUSION: In contrast to previous reports, SCNSL presented as parenchymal disease. MRI is not sufficient for differentiation between primary and secondary CNS lymphoma.

Hematooncology Department 3rd Faculty of Medicine Faculty Hospital Kralovske Vinohrady Charles University Prague Czech Republic

Institute of Anatomy 2nd Faculty of Medicine Charles University Prague Czech Republic

Pathology Department 3rd Faculty of Medicine Faculty Hospital Kralovske Vinohrady Charles University Prague Czech Republic

Radiology Department 3rd Faculty of Medicine Faculty Hospital Kralovske Vinohrady Charles University Prague Czech Republic

Radiology Department Na Homolce Hospital Prague Czech Republic

Zobrazit více v PubMed

Haioun C, Besson C, Lepage E, et al. Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin’s lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: a GELA study on 974 patients. Groupe d’Etudes des Lymphomes de l’Adulte. Ann Oncol. 2000;11(6):685–690. PubMed

Jahnke K, Thiel E, Martus P, Schwartz S, Korfel A. Retrospective study of prognostic factors in non-Hodgkin lymphoma secondarily involving the central nervous system. Ann Hematol. 2006;85(1):45–50. PubMed

Bernstein SH, Unger JM, Leblanc M, Friedberg J, Miller TP, Fisher RI. Natural history of CNS relapse in patients with aggressive non-Hodgkin’s lymphoma: a 20-year follow-up analysis of SWOG 8516 – the Southwest Oncology Group. J Clin Oncol. 2009;27(1):114–119. PubMed PMC

Villa D, Connors JM, Shenkier TN, Gascoyne RD, Sehn LH, Savage KJ. Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: the impact of the addition of rituximab to CHOP chemotherapy. Ann Oncol. 2010;21(5):1046–1052. PubMed

Bierman P, Giglio P. Diagnosis and treatment of central nervous system involvement in non-Hodgkin’s lymphoma. Hematol Oncol Clin North Am. 2005;19(4):597–609. PubMed

Grimm S, Chamberlain M. Hodgkin’s lymphoma: a review of neurologic complications. Adv Hematol. 2011;2011:624578. PubMed PMC

Haldorsen IS, Espeland A, Larsson E-M. Central nervous system lymphoma: characteristic findings on traditional and advanced imaging. Am J Neuroradiol. 2011;32(6):984–992. PubMed PMC

Hill QA, Owen RG. CNS prophylaxis in lymphoma: who to target and what therapy to use. Blood Rev. 2006;20(6):319–332. PubMed

Keldsen N, Michalski W, Bentzen SM, Hansen KB, Thorling K. Risk factor for central nervous system involvement in non-Hodgkins-lymphoma – a multivariable analysis. Acta Oncol. 1996;35(6):703–708. PubMed

van Besien K, Ha CS, Murphy S, et al. Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma. Blood. 1998;91(4):1178–1184. PubMed

Zinzani PL, Magagnoli M, Ferezza G, et al. Isolated central nervous system relapse in aggressive non-Hodgkin’s lymphoma: the Bologna experience. Leuk Lymphoma. 1999;32(5–6):571–576. PubMed

Hollender A, Kvaloy S, Nome O, Skovlund E, Lote K, Holte H. Central nervous system involvement following diagnosis of non-Hodgkin’s lymphoma: a risk model. Ann Oncol. 2002;13(7):1099–1107. PubMed

Pittman M, Treese S, Chen L, et al. Utility of flow cytometry of cerebrospinal fluid as a screening tool in the diagnosis of central nervous system lymphoma. Arch Pathol Lab Med. 2013;137(11):1610–1618. PubMed

Bhagavathi S, Wilson JD. Primary central nervous system lymphoma. Arch Pathol Lab Med. 2008;132(11):1830–1834. PubMed

Koubska E, Weichet J, Malikova H. Central nervous system lymphoma: a morphological MRI study. Neuro Endocrinol Lett. 2016;37(4):318–324. PubMed

Hernández Rubio L, Giner Bernabeu JC, Perez Sempere A, Toro P. Primary cerebral lymphoma with spontaneous remission. Neurologia. 2013;28(2):123–126. PubMed

Malikova H, Koubska E, Weichet J, et al. Can morphological MRI differentiate between primary central nervous system lymphoma and glioblastoma? Cancer Imaging. 2016;16(1):40. PubMed PMC

Haldorsen IS, Kråkenes J, Krossness BK, Mella O, Espeland A. CT and MR imaging features of primary central nervous system lymphoma in Norway, 1989–2003. Am J Neuroradiol. 2009;30(4):744–751. PubMed PMC

Senocak E, Oguz KK, Ozgen B, et al. Parenchymal lymphoma of the brain on initial MR imaging: a comparative study between primary and secondary brain lymphoma. Eur J Radiol. 2011;79(2):288–294. PubMed

Malikova H, Liscak R, Latnerova I, et al. Complications of MRI-guided stereotactic biopsy of brain lymphoma. Neuro Endocrinol Lett. 2014;35(7):613–618. PubMed

Primary central nervous system lymphoma: is whole-body CT and FDG PET/CT for initial imaging reasonable?